Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

850
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
850

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry.

European heart journal·2026
Same author

Isolated Rectal Polypoid Lesion as the Initial Presentation of Crohn's Disease.

ACG case reports journal·2026
Same author

Utility of Right Ventricular Mass Ratios in Recipients With Pulmonary Hypertension: A United Network for Organ-Sharing Database Analysis.

Clinical transplantation·2026
Same author

Compensating Heart Failure Cardiologists: Is the RVU Model the Right Model?

Circulation. Heart failure·2026
Same author

Prognostic factors and progression biomarkers in AL amyloidosis: mapping current knowledge and critical gaps.

Blood·2026
Same author

Trends in Private Equity Affiliations With Fertility Clinics in the US.

JAMA·2025

Related Experiment Video

Updated: May 6, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K

Characterizing Survival for Patients Supported With Inotropes After the 2018 Donor Allocation Restructuring: A UNOS

Christopher Pritting1, Joshua Chen2, Abdulmojeed Ekiyoyo3

  • 1Department of Surgery, Bayhealth Medical Center, Dover, Delaware, USA.

Clinical Transplantation
|March 4, 2025
PubMed
Summary

The 2018 UNOS donor heart allocation policy revision increased temporary support use (ECMO, tMCS, IABP) and improved heart transplant (HTx) survival rates for patients on inotropes. This policy change led to more transplants and better outcomes.

Keywords:
UNOSheart allocation policyinotropetransplant

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

636

Related Experiment Videos

Last Updated: May 6, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

636

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Public Health Policy

Background:

  • The 2018 revision of the United Network for Organ Sharing (UNOS) donor heart allocation policy aimed to adapt to changing transplant landscapes.
  • Understanding the impact of this policy on patient selection and outcomes, particularly for those requiring inotropic support, is crucial.

Purpose of the Study:

  • To characterize adaptive changes in heart transplant (HTx) candidate management following the 2018 UNOS policy revision.
  • To estimate long-term survival trends for HTx recipients in relation to inotropic support and mechanical circulatory support devices.

Main Methods:

  • Retrospective analysis of UNOS database for patients listed for HTx before (July 2014-July 2016) and after (October 2018-October 2020) the policy revision.
  • Examined trends in device progression (inotropes to ECMO, LVAD, tMCS, IABP) and survival post-transplantation.

Main Results:

  • The post-policy period saw increased transplantation rates for patients supported with intra-aortic balloon pump (IABP), temporary mechanical circulatory support (tMCS), and extracorporeal membranous oxygenator (ECMO).
  • Fewer patients were transplanted on inotropes or durable left ventricular assist devices (LVADs) post-policy, with a significant increase in progression from inotropes to other support forms.
  • Waitlisted patients post-policy had higher transplantation rates (89.8% vs. 78.9%) and improved survival (19.1% mortality vs. 26.9%).

Conclusions:

  • The 2018 UNOS policy revision shifted utilization towards temporary support devices (ECMO, tMCS, IABP) and away from durable LVADs.
  • Policy revisions resulted in increased transplantation and improved survival for patients on inotropes.
  • Survival rates were comparable across different forms of temporary support utilized post-transplantation.